We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.18B
AUM Growth
-$215M
Cap. Flow
+$233M
Cap. Flow %
10.67%
Top 10 Hldgs %
53.45%
Holding
100
New
9
Increased
46
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.3M
2
BIIB icon
Biogen
BIIB
+$45.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.2M
4
MRK icon
Merck
MRK
+$26.9M
5
STJ
St Jude Medical
STJ
+$25.3M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$26.6M
2
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$25.4M
3
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$25.3M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$21.7M
5
HALO icon
Halozyme
HALO
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
51
Cigna
CI
$79.2B
$7.55M 0.35%
55,904
-27,148
-33% -$3.94M
KPTI icon
52
Karyopharm Therapeutics
KPTI
$154M
$7.51M 0.34%
47,531
– –
TTPH
53
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$5.16M 0.24%
34,602
-10,052
-23% -$7.38M
PRGO icon
54
Perrigo
PRGO
$1.45B
$4.22M 0.19%
26,861
+81
+0.3% +$14.9K
BHC icon
55
Bausch Health
BHC
$1.7B
$3.18M 0.15%
17,839
-2,242
-11% -$523K
ZSPH
56
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$2.76M 0.13%
42,000
-423,839
-91% -$25.4M
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.47M 0.11%
150,343
+20,801
+16% +$426K
MNK
58
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.45M 0.11%
38,252
+2,707
+8% +$268K
EGRX
59
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.08M 0.1%
28,152
-17
-0.1% -$1.41K
AKRX
60
DELISTED
Akorn Inc
AKRX
$1.95M 0.09%
68,513
+1,115
+2% +$46.1K
IPXL
61
DELISTED
Impax Laboratories, Inc.
IPXL
$1.84M 0.08%
52,311
+1,396
+3% +$62.9K
OMED
62
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.81M 0.08%
109,211
-1,260,323
-92% -$25.3M
ALKS icon
63
Alkermes
ALKS
$8.13B
$1.76M 0.08%
30,011
+1,088
+4% +$71.8K
MCK icon
64
McKesson
MCK
$106B
$1.71M 0.08%
9,224
+256
+3% +$54.3K
ENDP
65
DELISTED
Endo International plc
ENDP
$1.71M 0.08%
24,636
+865
+4% +$69.2K
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$16.1B
$1.65M 0.08%
12,406
+458
+4% +$78.9K
LCI
67
DELISTED
Lannett Company, Inc.
LCI
$1.4M 0.06%
8,448
+299
+4% +$65.6K
ASRT
68
DELISTED
Assertio
ASRT
$1.36M 0.06%
1,200
+31
+3% +$52.9K
HZNP
69
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.34M 0.06%
67,852
+2,351
+4% +$74.3K
NKTR icon
70
Nektar Therapeutics
NKTR
$2.3B
$1.14M 0.05%
6,960
+303
+5% +$53.6K
PCRX icon
71
Pacira BioSciences
PCRX
$1.05B
$754K 0.03%
18,357
+725
+4% +$44.4K
CBPO
72
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$614K 0.03%
+6,840
New +$722K
CBM
73
DELISTED
Cambrex Corporation
CBM
$610K 0.03%
15,368
+624
+4% +$29.2K
ASND icon
74
Ascendis Pharma A/S
ASND
$16.6B
$550K 0.03%
31,100
-204,460
-87% -$3.98M
AMPH icon
75
Amphastar Pharmaceuticals
AMPH
$907M
$489K 0.02%
41,800
+5,400
+15% +$81K
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sectoral Asset Management held 100 positions worth $2.18B, down 9% from $2.4B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management deployed $233M of net new capital in Q3 2015, opening 9 new positions and adding to 46 existing holdings. Its largest new stake was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier.

On the sell side, the largest reduction was ZS PHARMA INC COMS TK (DE), an estimated $25.4M trimmed.

  • Sectoral Asset Management's largest Q3 2015 buy was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.
  • Sectoral Asset Management added most to Gilead Sciences in Q3 2015, an estimated $61.3M increase.
  • Sectoral Asset Management's biggest Q3 2015 reduction was ZS PHARMA INC COMS TK (DE), cutting an estimated $25.4M.
  • Sectoral Asset Management fully exited Abbott in Q3 2015, selling an estimated $26.6M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $2.18B portfolio in Q3 2015.
  • Sectoral Asset Management opened 9 new positions and closed 23 in Q3 2015.
  • Sectoral Asset Management's portfolio value fell 9% quarter-over-quarter to $2.18B.

Based on Sectoral Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.